National Institutes of Health (NIH) grants for non-US applicants

11-7-2018 By Peter van den Berghe

The NIH funding program has a wealth of funding opportunities and more importantly, it is open to non-US applicants (both companies and academic groups). This is all good news, but how to get such a grant?

Tips for European NIH applicants

Do you have unique technology or knowledge that is not available in the US?

Before you start your NIH grant, make sure that reviewers will not ask: “Why should the US pay for something that US researchers can do as well?” The single most important criteria to be successful at NIH is to bring technology, innovation and knowledge that they do not have in the US.

NIH specially welcomes non-US key opinion leaders that can advance science in the US. If you are not a Key opinion leader yet, you should not worry. Do your homework and team up with a US key Opinion Leader in your field to collaborate with.

Pitch yourself and your project to the NIH project officer

The NIH funding scheme consist on many specific funding opportunities announcements (FOA). All with a very distinct set of requirements.

Before you start writing you should start with the following exercise:

  • What are the objectives of the FOA and objectives of the NIH departments
  • What are the objectives of your project: called Specific Aims in NIH jargon
  • Make sure the Specific Aims match with the objectives of the FOA
  • Identify the required expertise for your project and when possible identify (US) consortium partners to collaborate with

The next step is a crucial one. Most FOAs ask you to send a letter of Intent. Take this opportunity and do more! Each FOA has a dedicated project officer who is often a scientist from the field. Use the LOI to get in contact with the project officer and pitch your Specific Aims during a phone call. This will help you to align your project with the goals of the FOA.

It is a no brainer but you need to learn the lingo and to start on time

As an NIH novice you need to learn many new abbreviations, from AOR, SO, DUNS, SAMS,, Assist and the list goes on and on and on … Do not worry you will get the jest. As fresh NIH applicant you also need to register your organization at several different sites. This registration process can take up to 6 -8 weeks and you should organize this well in advance. Thus, make sure to spot your favorite FOA in time to not miss out on the best NIH grant for you project.

Increase your chances

Are you unsure whether you have a technology which is not available in the US? Do you want advice how to proceed or help with developing a competitive proposal?

Our experts have experience with life science non-US NIH applications. We can analyse your case and help you develop the right strategy. Contact us and let’s talk about your ideas and ambitions.

Should you apply for a Eurostars or Fast Track to Innovation grant?

03-7-2018 By Rick Kwekkeboom During the long years of product development, keeping your company financially healthy can be challenging, especially when you cannot rely on a steady stream of revenues. During this period, a strategic mix of non-dilutive funding can give you just that financial boost to reach the market. Yet, the number of funding… Continue Reading

What does your company need to stand out in H2020 SME instrument?

28-6-2017 By Reinoud Brenkman and Peter Ochodnicky For an innovative small and medium-sized enterprise (SME) in life science, medical/health technology or drug development, Horizon2020 SME instrument (SMEi) is THE funding opportunity you need to have. It is by far the largest EU subsidy scheme available for a single company (up to €2.5 million for two… Continue Reading

WBSO: Everything you need to know

WBSO is a tax-deduction that is of major influence to the successful R&D projects of the Dutch LSH-sector. It drives innovations and enables companies in taking on riskier R&D-projects. Impact of WBSO on the LSH-sector In 2016, Catalyze performed a qualitative study to the impact of WBSO on the LSH-sector in the Netherlands. By conducting… Continue Reading



The REACTION! Project comprises a direct-aid response to the EBOLA crisis in 2015. The project was initiated by an international project team to provide rapid aid and health-care to the Ebola-infected population in Guinea, and by directly collecting rapid evidence of the efficacy of Favipiravir in reducing the mortality and Ebola viral load in the… Continue Reading

Lessons from successful scientific entrepreneurs for biotech start-ups

Lessons from successful scientific entrepreneurs for biotech start-ups

The biotechnology landscape is complex and defining a business strategy that will lead to success is challenging. Many companies struggle to define the roadmap towards success and to bridge the gap from being a start-up towards reaching an IPO, trade sale or launch onto the market of their product. Specifically, the lack of profit during… Continue Reading

Jalal Es-Sbai – Founder and director

Jalal Es-Sbai – Founder and director

Jalal Es-Sbai is a co-founder of DDF Services, now known as Catalyze. Jalal Es-Sbai has raised >100 million Euro in subsidies and grants for different types of organizations. Jalal specializes in business development and financing strategies for innovative companies in multiple sectors (life sciences, energy, valorization and technology).  Continue Reading

Quirein te Roller – Commercial Director

Quirein te Roller – Commercial Director

As Commercial Director, Quirein is responsible for all Sales and Business Development operations, both in The Netherlands and abroad. Within Catalyze, he furthermore leads the Marketing & Communication activities as well as the Strategic Funding Unit (SFU). This Unit provides in-depth and strategic funding advice to the growing Life Sciences Community. Continue Reading


Welcome at Catalyze!

Catalyze uses cookies in order to improve your user experience. By using this website you agree to our policy.

Go back or